Status: Recruiting
A Study of BGM0504 Tablets in Healthy Chinese Subjects
A randomized, open-label, multiple-dose study to evaluate the effects of high-fat meals and different administration conditions (including water intake and fasting time) on the pharmacokinetics of BGM0504 tablets at a dose of 20mg in healthy Chinese participants and to assess its safety and tolerability.
Participants needed: 144
Trial details
Phase: Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: BrightGene Bio-Medical Technology Co., Ltd.Updated: May 5, 2026Locations: 1
Eligibility criteria
○ Between the ages of 18 and 55 years (inclusive) at the time of screening, both... [+4]
● (Medical Inquiry) Individuals with a history of severe drug allergies (especia... [+19]